A Novel Fc-Optimized Antibody Drug Conjugate Targeting CD7 is Active in Preclinical Models of T-ALL

被引:0
|
作者
Gehlert, C. L. [1 ]
Schewe, D. M. [2 ]
Klausz, K. [1 ]
Schrappe, M. [1 ]
Cario, G. [1 ]
Baldus, C. D. [1 ]
Gramatzki, M. [1 ]
Lenk, L. [1 ]
Kellner, C. [2 ]
Peipp, M. [1 ]
机构
[1] Univ Hosp Schleswig Holstein, Kiel, Germany
[2] Otto von Guericke Univ, Magdeburg, Germany
来源
KLINISCHE PADIATRIE | 2024年 / 236卷 / 03期
关键词
D O I
10.1055/s-0044-1786578
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
0027
引用
收藏
页码:205 / 205
页数:1
相关论文
共 50 条
  • [1] A Novel Fc-Optimized Antibody Drug Conjugate Targeting CD7 As a Therapeutic Strategy in T-Cell Acute Lymphoblastic Leukemia
    Gehlert, Carina Lynn
    Schewe, Denis Martin
    Klausz, Katja
    Krohn, Steffen
    Winterberg, Dorothee
    Vogiatzi, Fotini
    Boje, Ammelie Svea
    Lux, Anja
    Nimmerjahn, Falk
    Scherliess, Regina
    Humpe, Andreas
    Schrappe, Martin
    Cario, Gunnar
    Valerius, Thomas
    Fransecky, Lars
    Brueggemann, Monika
    Baldus, Claudia D.
    Gramatzki, Martin
    Lenk, Lennart
    Kellner, Christian
    Peipp, Matthias
    BLOOD, 2023, 142
  • [2] EFFICIENT T-ALL THERAPY WITH CD7 IN A PRECLINICAL XENOGRAFT MODEL - ANTIBODY TH-69 LEADS TO COMPLETE NECROSIS OF THE TUMOR
    GRAMATZKI, M
    BAUM, W
    HANSENHAAGE, TE
    KRESSEL, M
    KREMMER, E
    STEININGER, E
    BAIR, HJ
    KALDEN, JR
    BECKER, W
    BLOOD, 1993, 82 (10) : A254 - A254
  • [3] Regulatory T Cell Depletion Using a CRISPR Fc-Optimized CD25 Antibody
    van Elsas, Marit J.
    van der Schoot, Johan M. S.
    Bartels, Alexander
    Steuten, Kas
    van Dalen, Duco
    Wijfjes, Zacharias
    Figdor, Carl G.
    van Hall, Thorbald
    van der Burg, Sjoerd H.
    Verdoes, Martijn
    Scheeren, Ferenc A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (15)
  • [4] Universal Anti-CD7 CAR-T Cells Targeting T-ALL and Functional Analysis of CD7 Antigen on T/CAR-T Cells
    Xie, Leling
    Gu, Runxia
    Yang, Xue
    Qiu, Shaowei
    Xu, Yingxi
    Mou, Junli
    Wang, Ying
    Xing, Haiyan
    Tang, Kejing
    Tian, Zheng
    Rao, Qing
    Wang, Min
    Wang, Jianxiang
    BLOOD, 2022, 140 : 4535 - 4535
  • [5] Universal Anti-CD7 CAR-T Cells Targeting T-ALL and Functional Analysis of CD7 Antigen on T/CAR-T Cells
    Xie, Leling
    Gu, Runxia
    Yang, Xue
    Qiu, Shaowei
    Xu, Yingxi
    Mou, Junli
    Wang, Ying
    Xing, Haiyan
    Tang, Kejing
    Tian, Zheng
    Rao, Qing
    Wang, Min
    Wang, Jianxiang
    HUMAN GENE THERAPY, 2023, 34 (23-24) : 1257 - 1272
  • [6] An Anti-CD7 Antibody-Drug Conjugate Target Showing Potent Antitumor Activity for T-Lymphoblastic Leukemia (T-ALL)
    Wang, Shiqi
    Zhang, Ruyuan
    Zhong, Kunhong
    Guo, Wenhao
    Tong, Aiping
    BIOMOLECULES, 2024, 14 (01)
  • [7] Immunocytokines and FC-optimized antibodies targeting B7-H3 (CD276) in neuroblastoma
    Heubach, Florian
    Schlegel, Patrick
    Zekri, Latifa
    Manz, Timo
    Schleicher, Sabine
    Rabsteyn, Armin
    Jung, Gundram
    Buehring, Hans-Joerg
    Gillies, Stephen D.
    Handgretinger, Rupert
    Lang, Peter
    BONE MARROW TRANSPLANTATION, 2019, 54 : 544 - 545
  • [8] Induction of NK cell reactivity against myeloid leukemia by a novel Fc-optimized CD133 antibody
    Schmied, B. J.
    Andre, M.
    Koerner, S.
    Leibold, J.
    Buehring, H. -J
    Haen, S.
    Kuebler, A.
    Kanz, L.
    Grosse-Hovest, L.
    Jung, G.
    Salih, H. R.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 135 - 135
  • [9] Development and Preclinical Characterization of an Fc-Optimized CD133 Antibody for Induction of NK Cell Reactivity Against Myeloid Leukemia
    Koerner, Samuel
    Leibold, Julia
    Grosse-Hovest, Ludger
    Buehring, Hans-Joerg
    Jung, Gundram
    Kanz, Lothar
    Salih, Helmut R.
    BLOOD, 2014, 124 (21)
  • [10] Preclinical development of a novel antibody-drug conjugate targeting "cold" tumors
    Kaplan, Angelo
    Attanasio, Nickolas
    Do, To Uyen T.
    Swaminathan, Sudha
    Bisht, Arnima
    Lou, San Lin
    Allen, Jason
    Boyd, Robert
    Ackroyd, James E.
    Feldman, Gleb
    Rohlff, Christian
    Dusek, Rachel L.
    CANCER RESEARCH, 2018, 78 (13)